AICAR Phosphate (Acadesine): Optimizing Apoptosis Workflows
2026-07-23
AICAR phosphate (Acadesine) stands out as a precision AMPK activator, enabling selective apoptosis induction in B-CLL and advanced cellular models. This guide unpacks robust protocols, troubleshooting advice, and reference-driven innovations to empower cancer and immunometabolic research.
Biotin-XX Tyramide Reagent: Precision in Cell Surface Labeli
2026-07-22
Biotin-XX Tyramide Reagent delivers unparalleled selectivity and sensitivity for cell surface protein profiling via tyramide signal amplification. Its membrane-impermeant design, validated in complex tissue settings, enables high-fidelity detection while minimizing background noise—making it the reagent of choice for advanced immunohistochemistry and in situ hybridization workflows.
Torin2: High-Precision mTOR Inhibitor for Cancer Research
2026-07-22
Torin2 is a highly potent, selective, and orally available mTOR inhibitor with nanomolar efficacy. It demonstrates 800-fold selectivity over PI3K and robust in vivo inhibition, making it a leading tool in mTOR pathway and cancer research applications. Its reliability is supported by recent peer-reviewed findings and detailed product documentation.
Gastroretentive Sponges for Alfuzosin HCl: MRI-Guided Innova
2026-07-21
This study introduces low-density gastroretentive sponges loaded with Alfuzosin HCl, designed to improve oral bioavailability and sustain drug release at the main absorption site. Using MRI in healthy volunteers, the research demonstrates prolonged gastric retention and optimized delivery, offering new avenues for benign prostatic hyperplasia research.
A40926: Dalbavancin Precursor and Glycopeptide Antibiotic Be
2026-07-21
A40926 is a natural glycopeptide antibiotic and the direct precursor of dalbavancin, exhibiting potent inhibition of Gram-positive bacteria and Neisseria gonorrhoeae. Its efficacy and well-defined mechanism make it a critical standard for Gram-positive infection and MRSA research.
PDHA1 Succinylation Drives Immune Escape in Cholangiocarcino
2026-07-20
A recent study reveals that succinylation of PDHA1 at lysine 83 in cholangiocarcinoma leads to alpha-ketoglutarate accumulation, which suppresses macrophage antigen presentation and promotes immune evasion. Targeting PDHA1 succinylation offers a promising approach to overcome chemotherapy resistance and modulate the tumor microenvironment.
Phenothiazines Drive Macrophage Antibacterial Activity via R
2026-07-20
This study demonstrates that phenothiazines, including perphenazine, significantly enhance macrophage antibacterial responses by inducing reactive oxygen species (ROS) and autophagy. These findings highlight a novel host-directed therapy mechanism for combating intracellular bacterial infections and inform new directions for translational and immunopharmacology research.
Cinoxacin: Precision Assays and Pharmacokinetics in UTI Rese
2026-07-19
Explore the distinctive pharmacokinetic profile and advanced assay integration of Cinoxacin, a leading quinolone antibiotic. This article provides a deep dive into its mechanism, optimized protocols, and unique value for urinary tract infection research.
Alfuzosin HCl: Selective α1 Adrenoceptor Antagonist Benchmar
2026-07-18
Alfuzosin HCl is a selective α1 adrenoceptor antagonist with high uroselectivity and a robust safety profile for benign prostatic hyperplasia (BPH) research. Its pharmacokinetics and in vitro benchmarks are precisely characterized, supporting evidence-driven experimental design.
BV6 IAP Antagonist: Applied Workflows for Cancer & Beyond
2026-07-17
BV6, a selective IAP antagonist from APExBIO, empowers researchers to induce apoptosis and sensitize cancer cells to therapy with precision. This guide details stepwise protocols, advanced use-cases, and troubleshooting strategies, translating recent mitochondrial apoptosis research into actionable lab workflows.
Redefining Polyadenylated mRNA Controls for Translational Su
2026-07-17
This thought-leadership article explores the strategic and mechanistic advances that ARCA EGFP mRNA (5-moUTP) brings to translational research. Bridging cap structure innovation, nucleotide modification, and polyadenylation, we examine how this next-generation polyadenylated mRNA overcomes immune activation and stability bottlenecks in mammalian cell transfection. Drawing on recent reference studies and real-world storage optimization, the article offers actionable guidance for researchers seeking robust, reproducible, and future-proofed fluorescence-based transfection controls—escalating the conversation beyond standard product overviews.
Tioconazole in Antifungal Research: Workflows & Optimization
2026-07-16
Tioconazole, a potent antifungal medication, is indispensable for dissecting ergosterol biosynthesis and modeling resistance in fungal infection research. This guide details robust experimental workflows, protocol parameters, and troubleshooting strategies, highlighting how Tioconazole from APExBIO empowers advanced antifungal drug development and high-fidelity in vitro models.
Unlocking Amikacin Sulfate: Precision Delivery in NTM Resear
2026-07-16
Amikacin Sulfate, a leading aminoglycoside antibiotic, is redefining research and clinical strategies against non-tuberculous mycobacterial (NTM) infections. This thought-leadership article synthesizes mechanistic insight, translational guidance, and comparative innovation, spotlighting the latest delivery paradigms and intracellular efficacy validated by recent studies. APExBIO’s Amikacin Sulfate emerges as a research-standard product, offering unmatched performance for translational scientists seeking targeted, high-impact bactericidal interventions.
Carbapenemase Gene Dynamics in CREC: Multi-Hospital Insights
2026-07-15
This study provides a detailed molecular and epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong, China. The findings clarify the prevalence, genetic localization, and transferability of key resistance determinants, informing both resistance surveillance and experimental modeling strategies.
LAMP1 Modulates CXCL10–CXCR3 Axis and Macrophage Polarizatio
2026-07-15
This study reveals that autophagy protein LAMP1 acts as a molecular switch in the CXCL10–CXCR3-mediated polarization of macrophages, dictating divergent responses under inflammatory versus non-inflammatory conditions. The findings highlight CXCR3 antagonism, particularly with AMG 487, as a precise tool for dissecting inflammation-driven macrophage phenotypes and mitigating acute lung injury.
460 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page